Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells

Lapatinib is an oral, small-molecule, dual tyrosine kinase inhibitor of epidermal growth factor receptors (EGFR, or ErbB/Her) in solid tumors. Little is known about the effect of lapatinib on leukemia. Using human chronic myelogenous leukemia (CML) K562 cells as an experimental model, we found that...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huey-Lan, Chen, Yu-Chieh, Huang, Yu-Chuen, Yang, Kai-Chien, Pan, Hsin yi, Shih, Shou-Ping, Chen, Yu-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245247/
https://www.ncbi.nlm.nih.gov/pubmed/22216158
http://dx.doi.org/10.1371/journal.pone.0029014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245247/
https://www.ncbi.nlm.nih.gov/pubmed/22216158
http://dx.doi.org/10.1371/journal.pone.0029014

Ejemplares similares